A Redox-Activated G-Quadruplex DNA Binder Based on a Platinum(IV)-Salphen Complex

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Molecular Biology

Background:

• G-quadruplex DNA structures are implicated in critical biological processes.
• These structures are attractive targets for novel drug development.
• Selective G-quadruplex binders are of significant research interest.

Purpose of the Study:

• To develop the first reduction-activated G-quadruplex DNA binder.
• To investigate the potential of platinum complexes as G-quadruplex targeting agents.

Main Methods:

• Synthesis of an octahedral platinum(IV)-salphen complex.
• Evaluation of DNA binding affinity under reducing conditions.
• In situ reduction studies using bioreductants like ascorbic acid and glutathione.

Main Results:

• The platinum(IV) complex showed no DNA interaction at physiological pH.
• Reduction to a platinum(II) complex was achieved in the presence of bioreductants.
• The generated platinum(II) complex exhibited significant affinity for G-quadruplex DNA.

Conclusions:

• A novel platinum(IV) complex acts as a prodrug, selectively binding G-quadruplex DNA upon bioreduction.
• This represents a promising strategy for targeted drug delivery to G-quadruplex structures.
• Further research into reduction-activated platinum complexes for G-quadruplex targeting is warranted.